Medicare Enrolled
Dr. Bethany Bergamo, M.D.
Dermatology · Hickory, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bergamo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bergamo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bergamo
Dr. Bethany Bergamo is a dermatology specialist in Hickory, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bergamo performed 6,779 Medicare services across 3,017 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bergamo received a total of $11,374 from 42 pharmaceutical and/or device companies across 545 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bergamo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 12% volume in NC
$11,374 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,779
Medicare services
Top 12% in NC for dermatology
3,017
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~357 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,919 | $5 | $16 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,177 | $56 | $217 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
583 | $36 | $161 |
| Ultrasound guidance for radiation therapy field placement Use of ultrasound imaging to help position radiation therapy fields accurately during treatment. |
528 | $136 | $426 |
| Radiation treatment planning, 1 area This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area. |
526 | $204 | $636 |
| Superficial or low voltage radiation treatment A radiation therapy procedure that delivers radiation to the surface of the body or uses low voltage energy. This treatment targets areas close to the skin. |
502 | $31 | $96 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
485 | $75 | $271 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
277 | $58 | $242 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
142 | $34 | $135 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
103 | $73 | $269 |
| Continuing radiation therapy consultation per week A weekly consultation to review and manage ongoing radiation therapy treatment. |
82 | $64 | $201 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
76 | $105 | $403 |
| Radiation treatment management, 5 sessions Oversight and management of a radiation therapy course consisting of five treatment sessions. |
69 | $149 | $463 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
61 | $35 | $120 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
54 | $85 | $307 |
| Calculation of radiation therapy dose | 31 | $51 | $158 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
30 | $118 | $428 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
29 | $299 | $977 |
| Simple radiation therapy planning This procedure involves the initial planning phase for radiation therapy treatment. It includes the setup and configuration required to prepare for delivering radiation to a specific area. |
24 | $53 | $171 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
20 | $34 | $173 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
17 | $136 | $462 |
| Design and construction of intermediate radiation treatment device This code covers the design and construction of an intermediate radiation treatment device. It does not specify a particular clinical purpose or condition. |
17 | $105 | $326 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
14 | $89 | $301 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
13 | $54 | $231 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,374
Total received (2018-2024)
Avg $1,625/year across 7 years
Top 15% in NC for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
545
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,036 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$338 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,355
2023
$1,503
2022
$1,425
2021
$1,411
2020
$356
2019
$2,198
2018
$2,126
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$397
ABBVIE INC.
$386
PFIZER INC.
$282
SUN PHARMACEUTICAL INDUSTRIES INC.
$224
Janssen Biotech, Inc.
$168
Dermavant Sciences, Inc.
$108
Arcutis Biotherapeutics, Inc.
$106
Lilly USA, LLC
$94
Amgen Inc.
$92
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
UCB, Inc.
$84
Galderma Laboratories, L.P.
$76
GENZYME CORPORATION
$65
Sandoz Inc.
$49
Medimetriks Pharmaceuticals, Inc.
$47
LEO Pharma Inc.
$23
Ortho Dermatologics, a division of Bausch Health US, LLC
$21
Organon Llc
$17
Genentech USA, Inc.
$16
Organogenesis Inc.
$15
Top 3 companies account for 45.2% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$1,232
AbbVie, Inc.
$1,024
Janssen Scientific Affairs, LLC
$803
AbbVie Inc.
$782
E.R. Squibb & Sons, L.L.C.
$639
ABBVIE INC.
$619
Sun Pharmaceutical Industries Inc.
$604
Janssen Biotech, Inc.
$599
UCB, Inc.
$541
Medimetriks Pharmaceuticals, Inc.
$440
Regeneron Healthcare Solutions, Inc.
$438
GENZYME CORPORATION
$427
LEO Pharma Inc.
$352
Novartis Pharmaceuticals Corporation
$343
Galderma Laboratories, L.P.
$295
SUN PHARMACEUTICAL INDUSTRIES INC.
$287
Lilly USA, LLC
$286
Journey Medical Corporation
$183
Dermavant Sciences, Inc.
$182
Celgene Corporation
$159
Boehringer Ingelheim Pharmaceuticals, Inc.
$155
Arcutis Biotherapeutics, Inc.
$153
Amgen Inc.
$138
Genentech USA, Inc.
$133
Ortho Dermatologics, a division of Bausch Health US, LLC
$59
VYNE Pharmaceuticals Inc.
$54
Allergan Inc.
$49
Sandoz Inc.
$49
Promius Pharma LLC
$43
Mentor Worldwide LLC
$41
Organogenesis Inc.
$37
EPI Health, LLC
$28
Mylan Pharmaceuticals Inc.
$28
STRATA Skin Sciences, Inc.
$26
Aclaris Therapeutics, Inc.
$24
Allergan, Inc.
$22
Fresenius Kabi USA, LLC
$20
Bayer HealthCare Pharmaceuticals Inc.
$18
Organon Llc
$17
Biofrontera Inc.
$16
Almirall LLC
$16
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 26.9% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ADBRY · AKLIEF · AMELUZ · AMZEEQ · APLIGRAF · ARAZLO · BLU-U · BOTOX · BOTOX COSMETIC · Bensal HP · Bimzelx · CIBINQO · COSENTYX · Cabtreo · Ceracade · Cimzia · Clindacin ETZ · Clindamycin Phosphate and Benzoyl Peroxide · Cloderm Cream · DERMATITIS - DISEASE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dermatological Psoriasis and Vitiligo Treatment · ENSTILAR · EPIDUO FORTE · ESTRING · EUCRISA · Erivedge · Exelderm · Finacea · Genadur · HADLIMA · HUMIRA · HYRIMOZ · Humira · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · LEVULAN KERASTICK · LITFULO · MENTOR MemoryGel Resterilizable Gel Sizer · Neo-Synalar · Neo-Synalar Cream · Neuac · ODOMZO (sonidegib) capsules · ORACEA · Odomzo · Otezla · Puraply · REMICADE · RHOFADE · RINVOQ · SIVEXTRO · SKYRIZI · SPEVIGO · Seysara · Sitavig · Sotyktu · TALTZ · TREMFYA · TWYNEO · TargaDox · Targadox · Tremfya · Trianex · ULTRAVATE · VTAMA · XTRAC · Xolair · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
10
Per 100K population
6.2
County median income
$64,544
Nearest hospital
CATAWBA VALLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bergamo is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NC), with low-engagement industry engagement in the top 15% of NC peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bergamo experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Bergamo performed 1,919 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bergamo receive payments from pharmaceutical companies?
Yes. Dr. Bergamo received a total of $11,374 from 42 companies across 545 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bergamo's costs compare to other dermatologists in Hickory?
Dr. Bergamo's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bergamo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Hickory
Browse dermatologists in Hickory ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NC
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NC
Which NC dermatologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology